Your email has been successfully added to our mailing list.

×
-0.264 -0.264 -0.388 -0.408 -0.4 -0.376 -0.41604 -0.42024
Stock impact report

Intellipharmaceutics to conduct new HAP study to support abuse-deterrent claim for Rexista [Seeking Alpha]

INTELLIPHARMACEUTICS (IPCI) 
Last intellipharmaceutics earnings: 10/15 05:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.intellipharmaceutics.com
Company Research Source: Seeking Alpha
In a statement issued after yesterday's negative Ad Com vote on oxycodone candidate Rexista, Intellipharmaceutics (NASDAQ: IPCI ) says it will conduct a new human abuse potential (HAP) study to support an abuse-deterrent claim for the oral and intranasal routes. It plans to initiate the study in the coming weeks. More data will be required to support an abuse-deterrent claim for the intravenous route as well, but the company does not disclose its plans for addressing this. The FDA's action date is September 25. Previously: FDA Ad Com thumbs down on Intellipharmaceutics' oxycodone (July 26) Now read: PetMed Express: $50 Looks Too High, But I've Been Wrong Before » Show less Read more
Impact Snapshot
Event Time:
IPCI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for IPCI alerts
Opt-in for
IPCI alerts

from News Quantified
Opt-in for
IPCI alerts

from News Quantified